Peter Gierschik

Albert Einstein Allee 11
Ulm, BW 89081, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia.

PLCG2 exon-skipped variants: insights into their potential role in chronic lymphocytic leukemia.

Journal: Blood advances

Published: November 13, 2025

Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity.

Rare Antagonistic Leptin Variants and Severe, Early-Onset Obesity.

Journal: The New England journal of medicine

Published: June 14, 2023

Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.

Acquired BTK mutations associated with resistance to noncovalent BTK inhibitors.

Journal: Blood advances

Published: September 14, 2022

Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.

Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS.

Journal: EMBO molecular medicine

Published: July 26, 2021

Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.

Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.

Journal: Blood

Published: March 01, 2021

Noncatalytic Bruton's tyrosine kinase activates PLCγ2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.

Noncatalytic Bruton's tyrosine kinase activates PLCγ2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells.

Journal: The Journal of biological chemistry

Published: November 18, 2019

cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 08, 2019

Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder.

Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder.

Journal: Oncotarget

Published: July 18, 2018

Functional and Phenotypic Characteristics of Human Leptin Receptor Mutations.

Functional and Phenotypic Characteristics of Human Leptin Receptor Mutations.

Journal: Journal of the Endocrine Society

Published: April 26, 2018

Estimated prevalence of potentially damaging variants in the leptin gene.

Estimated prevalence of potentially damaging variants in the leptin gene.

Journal: Molecular and cellular pediatrics

Published: April 27, 2017

Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency.

Measurement of immunofunctional leptin to detect and monitor patients with functional leptin deficiency.

Journal: European journal of endocrinology

Published: September 29, 2016

The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein.

The Phospholipase Cγ2 Mutants R665W and L845F Identified in Ibrutinib-resistant Chronic Lymphocytic Leukemia Patients Are Hypersensitive to the Rho GTPase Rac2 Protein.

Journal: The Journal of biological chemistry

Published: July 15, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026